Hyperglycemia aggravates decrease in alpha-synuclein expression in a middle cerebral artery occlusion model |
Kang, Ju-Bin
(Department of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University)
Kim, Dong-Kyun (Department of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University) Park, Dong-Ju (Department of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University) Shah, Murad-Ali (Department of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University) Kim, Myeong-Ok (Division of Life Science and Applied Life Science, College of Natural Sciences, Gyeongsang National University) Jung, Eun-Jung (Department of Endocrine Surgery, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital) Lee, Han-Shin (Department of Endocrine Surgery, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital) Koh, Phil-Ok (Department of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University) |
1 | Zhu M, Qin ZJ, Hu D, Munishkina LA, Fink AL. Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles. Biochemistry 2006; 45(26): 8135-8142. DOI |
2 | Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM. Exogenous -synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011; 72(1): 57-71. DOI |
3 | Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VM. Pathological -synuclein transmission initiates Parkinsonlike neurodegeneration in nontransgenic mice. Science 2012; 338(6109): 949-953. DOI |
4 | Makoto H, Eliezer M. Alpha-synuclein in Lewy Body Disease and Alzheimer's Disease. Brain Pathol 1999; 9: 707-720. DOI |
5 | Newell KL, Boyer P, Gomez-Tortosa E, Hobbs W, Hedley-Whyte ET, Vonsattel JP, Hyman BT. Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury. J Neuropathol Exp Neurol 1999; 58(12): 1263-1268. DOI |
6 | Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32(10): 2426-2432. DOI |
7 | Li ZG, Britton M, Sima AA, Dunbar JC. Diabetes enhances apoptosis induced by cerebral ischemia. Life Sci 2004; 76(3): 249-262. DOI |
8 | Rizk NN, Rafols J, Dunbar JC. Cerebral ischemia induced apoptosis and necrosis in normal and diabetic rats. Brain Res 2005; 1053(1-2): 1-9. DOI |
9 | Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 1993; 24(1): 111-116. DOI |
10 | Bruno A, Liebeskind D, Hao Q, Raychev R; UCLA Stroke Investigators. Diabetes mellitus, acute hyperglycemia, and ischemic stroke. Curr Treat Options Neurol 2010; 12(6): 492-503. DOI |
11 | Koh PO. Cerebral ischemic injury decreases -synuclein expression in brain tissue and glutamate-exposed HT22 cells. Lab Anim Res 2017; 33(3): 244-250. DOI |
12 | Tancrede G, Rousseau-Migneron S, Nadeau A. Long-term changes in the diabetic state induced by different doses of streptozotocin in rats. Br J Exp Pathol 1983; 64(2): 117-123. |
13 | Ye X, Chopp M, Cui X, Zacharek A, Cui Y, Yan T, Shehadah A, Roberts C, Liu X, Lu M, Chen J. Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats. Exp Neurol 2011; 232(2): 299-308. DOI |
14 | Ezquer M, Urzua CA, Montecino S, Leal K, Conget P, Ezquer F. Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice. Stem Cell Res Ther 2016; 7: 42. DOI |
15 | Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20(1): 84-91. DOI |
16 | Shah FA, Park DJ, Koh PO. Identification of Proteins Differentially Expressed by Quercetin Treatment in a Middle Cerebral Artery Occlusion Model: A Proteomics Approach. Neurochem Res 2018; 43: 1608-1623. DOI |
17 | Ning R, Chopp M, Zacharek A, Yan T, Zhang C, Roberts C, Lu M, Chen J. Neamine induces neuroprotection after acute ischemic stroke in type one diabetic rats. Neuroscience 2014; 257: 76-85. DOI |
18 | Qin Z, Hu D, Han S, Reaney SH, Di Monte DA, Fink AL. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. J Biol Chem 2007; 282(8): 5862-5870. DOI |
19 | Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, Aid S, Poumes-Ballihaut C, Champeil-Potokar G, Lavialle M. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev 2004; 44(6): 509-538. DOI |
20 | Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ. The formation of highly soluble oligomers of alphasynuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 2003; 37(4): 583-595. DOI |
21 | Kaplan B, Ratner V, Haas E. Alpha-synuclein: its biological function and role in neurodegenerative diseases. J Mol Neurosci 2003; 20(2): 83-92. DOI |
22 | Lee WC, Wong HY, Chai YY, Shi CW, Amino N, Kikuchi S, Huang SH. Lipid peroxidation dysregulation in ischemic stroke: plasma 4-HNE as a potential biomarker? Biochem Biophys Res Commun 2012; 425(4): 842-847. DOI |
23 | Ma QL, Chan P, Yoshii M, Ueda K. Alpha-synuclein aggregation and neurodegenerative diseases. J Alzheimers Dis 2003; 5(2): 139-148. DOI |
24 | Lee M, Hyun D, Halliwell B, Jenner P. Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J Neurochem 2001; 76(4): 998-1009. DOI |
25 | Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003; 66(8): 1499-1503. DOI |
26 | Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371(9624): 1612-1623. DOI |
27 | Jiang YF, Liu ZQ, Cui W, Zhang WT, Gong JP, Wang XM, Zhang Y, Yang MJ. Antioxidant effect of salvianolic acid B on hippocampal CA1 neurons in mice with cerebral ischemia and reperfusion injury. Chin J Integr Med 2015; 21(7): 516-522. DOI |
28 | Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H, Maier CM, Narasimhan P, Goeders CE, Chan PH. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 2011; 14(8): 1505-1517. DOI |
29 | Kleikers PW, Wingler K, Hermans JJ, Diebold I, Altenhofer S, Radermacher KA, Janssen B, Gorlach A, Schmidt HH. NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury. J Mol Med (Berl) 2012; 90(12): 1391-1406. DOI |
30 | Nigam S, Schewe T. Phospholipase A(2)s and lipid peroxidation. Biochim Biophys Acta 2000; 1488(1-2): 167-181. DOI |
31 | Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281(5381):1309-1312. DOI |
32 | Kuribayashi Y, Yoshida K, Sakaue T, Okumura A. In vitro studies on the influence of L-ascorbic acid 2-[3,4-dihydro- 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6yl-hy drogen phosphate] potassium salt on lipid peroxidation and phospholipase A2 activity. Arzneimittelforschung 1992; 42(9): 1072-1074. |
33 | Block F, Kunkel M, Sontag KH. Posttreatment with EPC-K1, an inhibitor of lipid peroxidation and of phospholipase A2 activity, reduces functional deficits after global ischemia in rats. Brain Res Bull 1995; 36(3): 257-260. DOI |
34 | Sidhu A, Wersinger C, Vernier P. Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J 2004; 18(6): 637-647. DOI |